Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality

References

• Hammes WP, Neuhaus FC. On the mechanism of action of vancomycin: inhibition of peptidoglycan synthesis in Gaffkya homari. Antimicrob Agents Chemother. 1974;6(6):722–728. doi:10.1128/AAC.6.6.722
   PubMed Web of Science ®Google Scholar
• Martin JH, Norris R, Barras M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists. Clin Biochem Rev. 2010;31(1):21.
   PubMedGoogle Scholar
• Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatr. Am J Heal Pharm. 2020;77(11):835–864.
   PubMed Web of Science ®Google Scholar
• Álvarez R, Cortés LEL, Molina J, Cisneros JM, Pachón J. Optimizing the clinical use of vancomycin. Antimicrob Agents Chemother. 2016;60(5):2601–2609.
   PubMed Web of Science ®Google Scholar
• Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Heal Pharm. 2009;66(1):82–98. doi:10.2146/ajhp080434
   PubMedGoogle Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–e55.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
   PubMed Web of Science ®Google Scholar
• Koliha K, Falk J, Patel R, Kier K. Comparative evaluation of pharmacist-managed vancomycin dosing in a community hospital following implementation of a system-wide vancomycin dosing guideline. J Pharm Pharmacol. 2017;5:607–615.
   Google Scholar
• Barceló-Vidal J, Rodríguez-García E, Grau S. Extremely high levels of vancomycin can cause severe renal toxicity. Infect Drug Resist. 2018;11:1027. doi:10.2147/IDR.S171669
   PubMed Web of Science ®Google Scholar
• de Almeida CDC, Silva ACS, de Queiroz OJA, et al. Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study. PLoS One. 2019;14(9):9. doi:10.1371/journal.pone.0222095
   Web of Science ®Google Scholar
• Jeffres MN. The whole price of vancomycin: toxicities, troughs, and time. Drugs. 2017;77(11):1143–1154. doi:10.1007/s40265-017-0764-7
   PubMed Web of Science ®Google Scholar
• Ye Z-K, Tang H-L, Zhai S-D. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. PLoS One. 2013;8(10):10. doi:10.1371/journal.pone.0077169
   Web of Science ®Google Scholar
• Mahmoodian A, Abbasi S, Farsaei S. A new approach to Vancomycin utilization evaluation: A cross-sectional study in intensive care unit. J Res Pharm Pract. 2016;5(4):279. doi:10.4103/2279-042X.192453
   PubMedGoogle Scholar
• Obara VY, Zacas CP, de Maio Carrilho CMD, Delfino VDA. Currently used dosage regimens of vancomycin fail to achieve therapeutic levels in approximately 40% of intensive care unit patients. Rev Bras Ter Intensiva. 2016;28(4):380. doi:10.5935/0103-507X.20160071
   PubMedGoogle Scholar
• Dib JG, Al-Tawfiq JA, Al Abdulmohsin S, Mohammed K, Jenden PD. Improvement in vancomycin utilization in adults in a Saudi Arabian Medical Center using the Hospital Infection Control Practices Advisory Committee guidelines and simple educational activity. J Infect Public Health. 2009;2(3):141–146. doi:10.1016/j.jiph.2009.07.002
   PubMedGoogle Scholar
• Wang J-T, Fang C-T, Chen Y-C, Chang S-C. Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother. 2001;47(2):246. doi:10.1093/jac/47.2.246
   PubMed Web of Science ®Google Scholar
• Truong J, Levkovich BJ, Padiglione AA. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels. Intern Med J. 2012;42(1):23–29. doi:10.1111/j.1445-5994.2011.02459.x
   PubMed Web of Science ®Google Scholar
• Reardon J, Lau TTY, Ensom MHH. Vancomycin loading doses: a systematic review. Ann Pharmacother. 2015;49(5):557–565. doi:10.1177/1060028015571163
   PubMed Web of Science ®Google Scholar
• van Hal SJ, Jones M, Gosbell IB, Paterson DL. Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections. PLoS One. 2011;6(6):6. doi:10.1371/journal.pone.0021217
   Web of Science ®Google Scholar
• Holmes NE, Turnidge JD, Munckhof WJ, et al. Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2013;57(4):1654–1663. doi:10.1128/AAC.01485-12
   PubMed Web of Science ®Google Scholar
• Shahrami B, Najmeddin F, Mousavi S, et al. Achievement of vancomycin therapeutic goals in critically ill patients: early individualization may be beneficial. Crit Care Res Pract. 2016;2016.
   Google Scholar
• Walraven CJ, North MS, Marr-Lyon L, Deming P, Sakoulas G, Mercier R-C. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2011;66(10):2386–2392. doi:10.1093/jac/dkr301
   PubMed Web of Science ®Google Scholar
• Moise PA, Smyth DS, El-Fawal N, et al. Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2008;61(1):85–90. doi:10.1093/jac/dkm445
   PubMed Web of Science ®Google Scholar
• Ortwine JK, Zasowski EJ, Pogue JM, et al. Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: it’s Complicated. Infect Dis Ther. 2019;8(4):627–640. doi:10.1007/s40121-019-00268-3
   PubMed Web of Science ®Google Scholar
• Legal M, Wan M. Influence of age on frequency of vancomycin dosing. Can J Hosp Pharm. 2010;63(1):13.
   PubMedGoogle Scholar
• O’Donnell JN, Rhodes NJ, Miglis CM, et al. Doses, durations, and gender predict vancomycin-induced kidney injury in pre-clinical studies. Int J Antimicrob Agents. 2018;51(2):239. doi:10.1016/j.ijantimicag.2017.08.012
   PubMed Web of Science ®Google Scholar
• Kovacevic T, Miljkovic B, Mikov M, et al. The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries. Dose-Response. 2019;17(2):1559325819850419. doi:10.1177/1559325819850419
   Web of Science ®Google Scholar
• Zonozi R, Wu A, Shin J-I. et al., Elevated vancomycin trough levels in a tertiary health system: frequency, risk factors, and prognosis. In: Mayo Clinic Proceedings. Vol. 94. Elsevier; 2019:17–26.
   Google Scholar
• Mohammadi M, Jahangard-Rafsanjani Z, Sarayani A, Hadjibabaei M, Taghizadeh-Ghehi M. Vancomycin-induced thrombocytopenia: a narrative review. Drug Saf. 2017;40(1):49–59. doi:10.1007/s40264-016-0469-y
   PubMed Web of Science ®Google Scholar
• Greco E, Lupia E, Bosco O, Vizio B, Montrucchio G. Platelets and multi-organ failure in sepsis. Int J Mol Sci. 2017;18(10):2200. doi:10.3390/ijms18102200
   PubMed Web of Science ®Google Scholar
• Aubron C, Corallo CE, Nunn MO, Dooley MJ, Cheng AC. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients. Ann Pharmacother. 2011;45(10):1193. doi:10.1345/aph.1Q195
   PubMed Web of Science ®Google Scholar
• Sakr Y, Elia C, Mascia L, et al. The influence of gender on the epidemiology of and outcome from severe sepsis. Crit Care. 2013;17(2):R50. doi:10.1186/cc12570
   PubMed Web of Science ®Google Scholar